✦ LIBER ✦

Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases

✍ Scribed by Desta, F; Christiansen, D H; Andersen, M K; Pedersen-Bjergaard, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of JAK2 V617F in B and T Cell

✍ Wang, Y. Lynn; Lee, Joong W.; Kui, Jonathan S.; Chadburn, Amy; Cross, Nicholas C 📂 Article 📅 2007 🏛 S. Karger AG 🌐 English ⚖ 221 KB

JAK2V617F as progression marker in CMPD

✍ Schnittger, S; Bacher, U; Kern, W; Haferlach, T; Haferlach, C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Expression of the JAK2 V617F mutation is

✍ Nishii, K; Nanbu, R; Lorenzo V, F; Monma, F; Kato, K; Ryuu, H; Katayama, N 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

The JAK2 V617F mutation involves B- and

✍ Thomas Stauffer Larsen; Jacob Haaber Christensen; Hans Carl Hasselbalch; Niels P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

UPD1p indicates the presence of MPL W515

✍ Szpurka, H; Gondek, L P; Mohan, S R; Hsi, E D; Theil, K S; Maciejewski, J P 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 259 KB

SETBP1 mutations occur in 9% of MDS/MPN

✍ Meggendorfer, M; Bacher, U; Alpermann, T; Haferlach, C; Kern, W; Gambacorti-Pass 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 453 KB